Assessment of circulating tumor cells in peripheral blood using flow cytometry in patients with surgery for colorectal cancer – review

1. Torino F, Bonmassar E, Bonmassar L, Vecchis L De, Barnabei A, Zuppi C, et al. Circulating tumor cells in colorectal cancer patients. Cancer Treat Rev. 2013;39(7):759-72. DOI: 10.1016/j.ctrv.2012.12.00710.1016/j.ctrv.2012.12.00723375250Search in Google Scholar

2. Dalum G Van, Stam G, Scholten LFA, Mastboom WJB. Importance of circulating tumor cells in newly diagnosed colorectal cancer. Int J Oncol. 2015;46:1361-8. DOI: 10.3892/ijo.2015.282410.3892/ijo.2015.282425572133Search in Google Scholar

3. Maestro LM, Sastre J, Rafael SB, Veganzones SB, Vidaurreta M, Martín M, et al. Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages. 2009;4844:4839-43.Search in Google Scholar

4. Venesio T, Siravegna G, Bardelli A, Sapino A. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers. Pathobiology. 2018;85(1-2):146-54. DOI: 10.1159/00047388210.1159/00047388228614831Search in Google Scholar

5. Sundling KE, Lowe AC. Circulating Tumor Cells : Overview and Opportunities in Cytology. Adv Anat Pathol. 2019 Jan;26(1):56-63.2019;26(1):56-63. DOI: 10.1097/PAP.000000000000021710.1097/PAP.000000000000021730325755Search in Google Scholar

6. Katsuno H, Zacharakis E, Aziz O, Ziprin P, Athanasiou T, Darzi A. Does the Presence of Circulating Tumor Cells in the Venous Drainage of Curative Colorectal Cancer Resections Determine Prognosis ? A Meta-Analysis. Ann Surg Oncol. 2008;15(11):3083-91. DOI: 10.1245/s10434-008-0131-810.1245/s10434-008-0131-818787906Search in Google Scholar

7. Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, et al. Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer. Gastroenterology. 2010;138(5):1714-26. DOI: 10.1053/j.gastro.2010.01.00810.1053/j.gastro.2010.01.00820100481Search in Google Scholar

8. Lu Y, Wang P, Peng J, Wang X, Zhu Y, Shen N. Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer. Sci Rep. 2017 Apr 19;7(1):905. DOI: 10.1038/s41598-017-01066-y10.1038/s41598-017-01066-y543045728424486Search in Google Scholar

9. Tan Y, Wu H. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. Curr Probl Cancer. 2018 Jan-Feb;42(1):95-106. DOI: 10.1016/j.currproblcancer.2017.11.00210.1016/j.currproblcancer.2017.11.00229277243Search in Google Scholar

10. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R, Rafael S, et al. Circulating tumor cells in colorectal cancer : correlation with clinical and pathological variables. Ann Oncol. 2008 May;19(5):935-8. DOI: 10.1093/annonc/mdm58310.1093/annonc/mdm58318212090Search in Google Scholar

11. Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P. Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review. Br J Cancer. 2010;102(9):1327-34. DOI: 10.1038/sj.bjc.660565110.1038/sj.bjc.6605651286576020389297Search in Google Scholar

12. Sales J, Wind P, Douard R. Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer. Lancet. 1999 Jul 31;354(9176):392. DOI: 10.1016/S0140-6736(99)92164-510.1016/S0140-6736(99)92164-5Search in Google Scholar

13. Chen WS, Chung MY, Liu JH, Liu JM, Lin JK. Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery. World J Surg. 2004;28(6):552-7. DOI: 10.1007/s00268-004-7276-910.1007/s00268-004-7276-915366744Search in Google Scholar

14. Ramdane Harouakaa, Zhigang Kangb, Siyang Zhenga and LC. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications. Pharmacol Ther. 2014 Feb; 141(2): 209-221. DOI: 10.1016/j.pharmthera.2013.10.00410.1016/j.pharmthera.2013.10.004394724724134902Search in Google Scholar

15. Vaiopoulos AG, Kostakis ID, Gkioka E, Christopoulos P, Gogas H, Kouraklis G, et al. Detection of Circulating Tumor Cells in Colorectal and Gastric Cancer Using a Multiplex PCR Assay. Anticancer research. 2014;34(6):3083-92.Search in Google Scholar

16. Assay T, Luca A De, Pignata S, Casamassimi A, Antonio AD, Gridelli C, et al. Detection of Circulating Tumor Cells in Carcinoma Patients by a Novel Epidermal Growth Factor Receptor Reverse. Clin Cancer Res. 2000;6:1439-44.Search in Google Scholar

17. Thorsteinsson M, Jess P. The clinical significance of circulating tumor cells in non-metastatic colorectal cancer e A review. Eur J Surg Oncol. 2011;37(6):459-65. DOI: 10.1016/j.ejso.2011.01.02510.1016/j.ejso.2011.01.02521324632Search in Google Scholar

18. Huang X, Gao P, Song Y, Sun J, Chen X, Zhao J, et al. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer. BMC Cancer. 2015;15:202. DOI: 10.1186/s12885-015-1218-910.1186/s12885-015-1218-9438931125880692Search in Google Scholar

19. Mund JA, Estes ML, Yoder MC, Ingram DA Jr, Case J. Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol. 2012;32(4):1045-1053. DOI: 10.1161/ATVBAHA.111.24421010.1161/ATVBAHA.111.244210330652922282356Search in Google Scholar

20. Duda DG, Cohen KS, Scadden DT, Jain RK. A protocol for phenotypic detection and numeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc. 2007;2(4):805-10. DOI: 10.1038/nprot.2007.11110.1038/nprot.2007.111268612517446880Search in Google Scholar

21. Huang X, Gao P, Song Y, Sun J, Chen X, Zhao J, et al. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis. BMC Cancer. 2014;14:976. DOI: 10.1186/1471-2407-14-97610.1186/1471-2407-14-976430214825519477Search in Google Scholar

22. Sun W, Li G, Wan J, Zhu J, Shen W, Zhang Z. Circulating tumor cells : A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy. Oncotarget. 2016;7(43):69507-17. DOI: 10.18632/oncotarget.1087510.18632/oncotarget.10875534249427486758Search in Google Scholar

23. Bünger S, Zimmermann M, Habermann JK. Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials. Cancer Metastasis Rev. 2015;34(3):527-45. DOI: 10.1007/s10555-015-9582-010.1007/s10555-015-9582-026323491Search in Google Scholar

24. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339(7716):332-6. DOI: 10.1136/bmj.b253510.1136/bmj.b2535271465719622551Search in Google Scholar

25. Fang C, Fan C, Wang C, Huang Q, Meng W, Yu Y, et al. Prognostic value of CD133+ CD54+ CD44+ circulating tumor cells in colorectal cancer with liver metastasis. Cancer Med. 2017;6(12):2850-57. DOI: 10.1002/cam4.124110.1002/cam4.1241572729929105339Search in Google Scholar

26. Galizia G, Gemei M, Orditura M, Romano C, Zamboli A, Castellano P, et al. Postoperative Detection of Circulating Tumor Cells Predicts Tumor Recurrence in Colorectal Cancer Patients. J Gastrointest Surg. 2013;17(10):1809-18. DOI: 10.1007/s11605-013-2258-610.1007/s11605-013-2258-623813048Search in Google Scholar

27. Tralhao, J.G Hoti, E, Serdio, M Laranjeiro P, Paiva A, Abrantes AM, Hoti E, Sero M. Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer. Eur J Surg Oncol. 2010;36(2):125-9. DOI: 10.1016/j.ejso.2009.07.00310.1016/j.ejso.2009.07.00319646840Search in Google Scholar

28. Cohen SJ, Alpaugh RK, Gross S, Hara SMO, Smirnov DA, Terstappen LWMM, et al. Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2006;6(2):125-32. DOI: 10.3816/CCC.2006.n.02910.3816/CCC.2006.n.02916945168Search in Google Scholar

29. Tseng J, Yang C, Liang S, Liu R, Yang S, Lin J. Inter-leukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases. Clin Cancer Res. 2014;20(11):2885-97. DOI: 10.1158/1078-0432.CCR-13-216210.1158/1078-0432.CCR-13-216224677375Search in Google Scholar

30. Tsavellas G, Huang A, Mccullough T, Patel H, Araia R. Flow cytometry correlates with RT-PCR for detection of spiked but not circulating colorectal cancer cells. Clin Exp Metastasis. 2002;19(6):495-502. DOI: 10.1023/A:102035011729210.1023/A:1020350117292Search in Google Scholar

31. Bahnassy AA, Salem SE, Mohanad M, Abulezz NZ, Abdellateif MS, Hussein M, et al. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non- metastatic colorectal cancer patients: A comparative study for four di ff erent techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorpholoqy). Exp Mol Pathol. 2019;106:90-101. DOI: 10.1016/j.yexmp.2018.12.00610.1016/j.yexmp.2018.12.00630578762Search in Google Scholar

32. Aghagolzadeh P, Radpour R. New trends in molecular and cellular biomarker discovery for colorectal cancer. World J Gastroenterol. 2016;22(25):5678-93. DOI: 10.3748/wjg.v22.i25.567810.3748/wjg.v22.i25.5678493220527433083Search in Google Scholar

33. Denis JA, Lacorte J-M. Detection of RAS mutations in circulating tumor cells: applications in colorectal cancer and prospects. Ann Biol Clin (Paris). 2017;75(6):607-18. DOI: 10.1684/abc.2017.130410.1684/abc.2017.130429192596Search in Google Scholar

34. Tsavellas G, Patel H, Allen-Mersh TG. Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg. 2001;88(10):1307-20. DOI: 10.1046/j.0007-1323.2001.01863.x10.1046/j.0007-1323.2001.01863.x11578283Search in Google Scholar

35. Wang L, Wang Y, Liu Y, Cheng M, Wu X, Wei H. Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection. J Exp Clin Cancer Res. 2009;28(1):57. DOI: 10.1186/1756-9966-28-5710.1186/1756-9966-28-57268512419397830Search in Google Scholar

36. Lopez A, Harada K, Mizrak Kaya D, Dong X, Song S, Ajani JA. Liquid biopsies in gastrointestinal malignancies: when is the big day? Expert Rev Anticancer Ther. 2018;18(1):19-38. DOI: 10.1080/14737140.2018.140332010.1080/14737140.2018.140332029202614Search in Google Scholar

37. Malara N, Trunzo V, Foresta U, Amodio N, Vitis S De, Roveda L. Ex vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment. J Transl Med. 2016;14(1):133. DOI: 10.1186/s12967-016-0876-y10.1186/s12967-016-0876-y486643627176720Search in Google Scholar

38. Vlems FA, Diepstra JHS, Cornelissen IMHA, Ruers TJM, Ligtenberg MJL, Punt CJA, et al. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue. J Clin Pathol - Mol Pathol. 2002;55(3):156-63. DOI: 10.1136/mp.55.3.15610.1136/mp.55.3.156118716812032226Search in Google Scholar

39. Søreide K, Watson MM, Lea D, Nordgård O, Søreide JA, Hagland HR. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): Study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis. J Transl Med. 2016;14(1):192. DOI: 10.1186/s12967-016-0951-410.1186/s12967-016-0951-4492827627357108Search in Google Scholar

40. Chou WC, Wu MH, Chang PH, Hsu HC, Chang GJ, Huang WK, et al. A prognostic model based on circulating tumour cells is useful for identifying the poorest survival outcome in patients with metastatic colorectal cancer. Int J Biol Sci. 2018;14(2):137-46. DOI: 10.7150/ijbs.2318210.7150/ijbs.23182582103529483832Search in Google Scholar

41. Connor AA, McNamara K, Al-Sukhni E, Diskin J, Chan D, Ash C, et al. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2016;23(7):2168-75. DOI: 10.1245/s10434-015-5038-610.1245/s10434-015-5038-626714949Search in Google Scholar

42. Rahbari NN, Bork U, Kircher A, Nimitz T, Schölch S, Kahlert C, et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann Surg Oncol. 2012;19(7):2195-202. DOI: 10.1245/s10434-011-2178-110.1245/s10434-011-2178-122230943Search in Google Scholar

43. Gogenur M, Hillig T, Gogenur I. CytoTrack analysis reveals low presence of circulating tumor cells in the perioperative period in patients with non-metastatic colorectal cancer. Anticancer Res. 2017;37(6):3099-103. DOI: 10.21873/anticanres.1166610.21873/anticanres.1166628551650Search in Google Scholar

44. Tsai WS, Chen JS, Shao HJ, Wu JC, Lai JM, Lu SH, et al. Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients. Sci Rep. 2016;6(3):4-11. DOI: 10.1038/srep2451710.1038/srep24517483094927075165Search in Google Scholar

45. Wu W, Zhang Z, Gao XH, Shen Z, Jing Y, Lu H, et al. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostainingfluorescence in situ hybridization (SE-iFISH). Oncotarget. 2017;8(13):21639-49. DOI: 10.18632/oncotarget.1545210.18632/oncotarget.15452540061228423493Search in Google Scholar

46. Bosch B, Guller U, Schnider A, Maurer R, Harder F, Metzger U, et al. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg. 2003;90(7):882-8. DOI: 10.1002/bjs.412910.1002/bjs.412912854118Search in Google Scholar

47. Seeberg LT, Brunborg C, Waage A, Hugenschmidt H, Renolen A, Stav I, et al. Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Ann Surg Oncol. 2017;24(8):2113-21. DOI: 10.1245/s10434-017-5818-210.1245/s10434-017-5818-2549163028258416Search in Google Scholar

48. Wind J, Tuynman JB, Tibbe AGJ, Swennenhuis JF, Richel DJ. Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. Eur J Surg Oncol. 2009;35(9):942-50. DOI: 10.1016/j.ejso.2008.12.00310.1016/j.ejso.2008.12.00319153024Search in Google Scholar

49. Abalde-cela S, Piairo P. The Significance of Circulating Tumour Cells in the Clinic. Acta Cytol. 2019:1-13. DOI: 10.1159/00049541710.1159/00049541730820013Search in Google Scholar

50. Schmidt T, Koch M, Antolovic D, Reissfelder C, Schmitz-winnenthal FH, Rahbari NN, et al. Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination - prospective randomized multicenter trial. BMC Surg. 2008;8:6. DOI: 10.1186/1471-2482-8-610.1186/1471-2482-8-6229214618321372Search in Google Scholar

51. Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: A meta-analysis. Ann Surg Oncol. 2013;20(7):2156-65. DOI: 10.1245/s10434-013-2907-810.1245/s10434-013-2907-823456317Search in Google Scholar